$XTRN$ STOP & READ: QUOTE: "XREE has secured a $7 million

New Post Public Reply Private Reply Replies (0) Message Board
guidelines
336
$XTRN$ STOP & READ: QUOTE: [b]"XREE has secured a $7 million equity line of credit from Ascendiant Capital Partners to build out its service."[/b]

Las Vegas Railway Express Inc (XTRN), the company developing a luxury train service called the “X Train,” from the Los Angeles basin to Las Vegas, exploded recently due to a buyout offer from X Rail Entertainment, Inc (XREE). In the press release, it was stated that shareholders of XTRN would be paid $20 million in a combination of cash and shares of XREE. We, like other traders on iHub, did our own research to establish the total amount being received. In this article, we will tell you everything you need to know,

Business

We checked the company website and found the business objectives of the company and the reasons to justify the train service. Have a look:

“We plan to offer a train service between Las Vegas and the Los Angeles metropolitan area by hiring Amtrak to haul our passenger cars for a fee. The proposed service, called the “X-Train,” will introduce a “Las Vegas” style experience on the train, while traversing the route in approximately 5 – 5 ½ hours.There has been no regular passenger rail service between the Los Angeles and Las Vegas areas for over 18 years. The only major highway between Los Angeles and Las Vegas is Interstate 15 (“I-15”). Of the more than 12 million annual visitors from the Southern California/Los Angeles market, 94% use automobile transportation to Las Vegas via this corridor every year.”

Source

Once we understood the business of XTRN, we wanted to know the reasons to justify its acquisition by XREE. We found out that the buyer is actually a direct competitor. We checked its website and saw that it offers “rail services from metropolitan areas in the US to resort gaming/casino destinations“. XREE has secured a $7 million equity line of credit from Ascendiant Capital Partners to build out its service.

Recent Developments

The merger

On May 23, 2017, the company announced that it had received an offer to acquire 100% of the company for $20 million in cash and stock of XREE. We did not have access to any acquisition contract, and the amount of shares of XREE was not specified. We made the following calculation in order to obtain the amount of money that XTRN shareholders would receive:

Merger contribution: 20 million
Number of shares outstanding (annual report): 783,520,592 shares
Contribution per share: $0.0255
Is $0.0255 a combination of shares and cash? Yes. In this case, if you are only interested in receiving cash, you may sell the shares right after you receive them. Investors willing to continue with the company, as the “X-Train” project seduced them, may keep them. At the end of the day, we believe that the final combination will keep developing the same idea.

The press release did not explain the synergies that the merger may bring, but noted that the consolidation will benefit shareholders.

“This consolidation of interests is being done to benefit the many shareholders who invested in the project of running trains between LA and Las Vegas and who may have had their equity diminished. We just want all those who helped us get here have an opportunity to participate in the rewards of execution on this project.” Source
Market reaction – Is there an opportunity?

The share price as of May 24, 2017 is $0.0019. Thus, the total returns if we buy now and get paid when the merger closes would be substantial. Why is this happening? In our opinion, the market did not believe the transaction. This can occur for several reasons. Let us review them.

The buyer has no cash to pay: in the balance sheet, the total amount of cash owned by XREE is $202,000. This may mean that the rest would have been paid in shares. The share price of XREE is worth $3.9, but it may decrease once the company discloses the amount of shares to be issued. The market does not have all the information about the merger yet, so we believe that it did not push up the shares of XTRN. If all the details are released, the jump may be substantial.
The buyer is not known: The market sometimes ignores companies that are too small or quite unknown. This is a micro-cap stock, so don’t expect everybody to know XREE.
Many market participants did not get to know the merger announcement: it is quite likely that shareholders did not get to know the news yet. In the following weeks, once the whole market gets to know the deal, the share price may be pushed up to be close to the offer price.
The buyer did not obtain the financing: this is quite likely as well. The buyer did not show any commitment from a bank that may lend money to acquire XTRN. Perhaps this information will be released soon. If the buyer puts out a commitment, the share price may jump.
Conclusion

Las Vegas Railway has a project that has caught the interest of a direct competitor, X Rail Entertainment. Both companies are trying to launch similar services, and it seems that the new merger between the two is an interesting idea. The SG&A expenses and R&D costs will be reduced, perhaps the business combination may bring some synergies, and the company will be bigger. Thus, banks will prefer the company (the credit risk will be lower). We calculated the offer price and saw that the XTRN share price is quite far from it. Hence, we tried to understand what was the problem. In our opinion, the press release issued did not disclose all the necessary information, thus the market is not fully recognizing its value yet. If the companies finally mention the amount of shares that shareholders will receive or show a commitment from a bank, the share price may jump. To sum up, stay alert, something good may be about to happen.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 7

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 6

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 7

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 5

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 5

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading

Top 5 Most Recently Viewed Articles

PMGC Capital's Strategic Investment in Alaunos Therapeutics

Updated Category News Views 171

PMGC Capital LLC Plans to File Schedule 13D on Alaunos PMGC Capital LLC, a fully owned subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), has made a significant move in the financial landscape by announcing its intention to file a Schedule 13D with the U.S. Securities and Exchange Commission (SEC). This filing will disclose its beneficial ownership in Alaunos Therapeutics,...

Continue Reading
Black Diamond Therapeutics: Pivotal Developments Ahead

Updated Category News Views 97

Black Diamond Therapeutics Continues to Make Strides Recently, H.C. Wainwright confirmed a Buy rating on Black Diamond Therapeutics (NASDAQ: BDTX) shares, projecting a price target of $11.00. This positive outlook follows the company's major restructuring efforts aimed at advancing BDTX-1535, its leading drug candidate, into pivotal trials. This move is expected to not...

Continue Reading
Eureka Acquisition Corp Announces New Meeting Date and Deadlines

Updated Category News Views 187

Eureka Acquisition Corp's Important Announcement New York — Eureka Acquisition Corp (NASDAQ: EURK), a special purpose acquisition company, has recently made significant announcements regarding the schedule of its extraordinary general meeting. Originally set for June 20, it will now take place on June 25, providing shareholders with extra time for participation. Details...

Continue Reading
Diamedica Therapeutics Hits New Heights with $6.41 Stock Value

Updated Category News Views 118

Diamedica Therapeutics Inc. Achieves 52-Week High Diamedica Therapeutics Inc. (NASDAQ: DMAC) is making headlines as its stock has recently hit a remarkable 52-week high of $6.41. This impressive milestone comes amid a significant growth phase for the company, which is currently valued at around $230 million. The steep rise in the stock price over the past year indicates a...

Continue Reading
J.P. Morgan's Projections for 2025: Capital Market Insights

Updated Category News Views 6083

J.P. Morgan's Capital Market Assumptions for 2025 J.P. Morgan Asset Management has recently unveiled its 2025 Long-Term Capital Market Assumptions (LTCMAs), providing valuable insights into the anticipated returns and risks across various asset classes for the next decade. These projections serve as a compass for investment strategies, targeting institutional and...

Continue Reading